Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

M Ravnborg, P Soelberg Sorensen, PS Sørensen, M Andersson, E Celius, P Jongen, I Elovaara, E Bartholomé, C Constantinescu, K Beer, E Garde, B Sperling

    Research output: Contribution to journalArticleScientificpeer-review

    72 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)672-680
    JournalLancet Neurol
    Issue number7
    Publication statusPublished - 2010
    Publication typeA1 Journal article-refereed

    Cite this